AIRLINK 74.65 Decreased By ▼ -0.51 (-0.68%)
BOP 5.42 Decreased By ▼ -0.03 (-0.55%)
CNERGY 4.40 Increased By ▲ 0.01 (0.23%)
DFML 29.30 Increased By ▲ 1.66 (6.01%)
DGKC 77.14 Increased By ▲ 5.14 (7.14%)
FCCL 21.39 Increased By ▲ 1.10 (5.42%)
FFBL 30.90 Decreased By ▼ -0.15 (-0.48%)
FFL 10.19 Increased By ▲ 0.22 (2.21%)
GGL 10.75 Increased By ▲ 0.48 (4.67%)
HBL 114.90 Decreased By ▼ -0.10 (-0.09%)
HUBC 130.95 Decreased By ▼ -0.50 (-0.38%)
HUMNL 6.80 Decreased By ▼ -0.07 (-1.02%)
KEL 4.08 Decreased By ▼ -0.12 (-2.86%)
KOSM 4.75 Decreased By ▼ -0.02 (-0.42%)
MLCF 39.78 Increased By ▲ 2.70 (7.28%)
OGDC 134.65 Decreased By ▼ -0.80 (-0.59%)
PAEL 24.20 Increased By ▲ 0.80 (3.42%)
PIAA 27.37 Increased By ▲ 0.06 (0.22%)
PIBTL 6.71 Increased By ▲ 0.11 (1.67%)
PPL 113.75 Increased By ▲ 0.59 (0.52%)
PRL 28.84 Increased By ▲ 0.09 (0.31%)
PTC 15.25 Decreased By ▼ -0.25 (-1.61%)
SEARL 57.41 Increased By ▲ 0.08 (0.14%)
SNGP 67.09 Increased By ▲ 0.10 (0.15%)
SSGC 11.15 Decreased By ▼ -0.02 (-0.18%)
TELE 9.20 Increased By ▲ 0.06 (0.66%)
TPLP 12.08 Increased By ▲ 0.03 (0.25%)
TRG 70.69 Increased By ▲ 0.30 (0.43%)
UNITY 23.82 Increased By ▲ 0.17 (0.72%)
WTL 1.33 Decreased By ▼ -0.01 (-0.75%)
BR100 7,476 Increased By 21.3 (0.29%)
BR30 24,359 Increased By 108.8 (0.45%)
KSE100 71,702 Increased By 268.9 (0.38%)
KSE30 23,644 Increased By 77.8 (0.33%)

imageISLAMABAD: China's vaccines are produced and regulated in accordance with international standards, and the hepatitis B vaccination program is vital in safeguarding children against the illness, according to the World Health Organization.

Bernhard Schwartlander, China representative for the international health body, made these points during an interview with China Daily.

"Given that the hepatitis B virus is still around, it's important for babies to get vaccinated," he said.

The WHO Beijing office met with the National Health and Family Planning Commission on Thursday to discuss the latest developments surrounding incidents in which 11 newborns have died after being inoculated against hepatitis B.

According to Schwartlander, it's difficult to establish a causal link between the vaccines and the babies' deaths since nearly all infants in China receive the vaccine as part of a very successful vaccination program.

Statistics from the commission showed that more than 16 million babies were born in China last year, and 90 percent of them were covered by the program that offers hepatitis B vaccinations free of charge.

"Without the immunization coverage, there might be a rapid increase of the disease," Schwartlander warned.

China initiated the hepatitis B vaccinations in 2002 under a

nationwide immunization program that began in 1978 and aims to protect children from preventable diseases.

The vaccines, which guard against more than 10 diseases, are all manufactured domestically, said Zhao Kai, a vaccine expert and academician with the Chinese Academy of Engineering.

Schwartlander called the program "very successful", saying that hepatitis B prevalence among Chinese children under the age of 5 is now below 1 percent.

But he conceded that some risks from the vaccination cannot be avoided.

According to the US Centers for Disease Control and Prevention, hepatitis B is a very safe vaccine, and most recipients have no problems with it. Severe problems are extremely rare. Dangerous allergic reactions are believed to occur about once in 1.1 million doses.

"Medical education is important for the public to fully understand the benefit and risk of the vaccine, thus enabling them to make the right choice," Schwartlander said.

Comments

Comments are closed.